3 ms·
> It probably highlights that we have more work to do to bring down the cost of insulin for more people ... > We want to do our part and work with payers in t
by advisedwang 4y ago
> It probably highlights that we have more work to do to bring down the cost of insulin for more people
...
> We want to do our part and work with payers in the system to provide copay assistance.
In other words: to a Pharma exec, "bring down cost" means that insurance and the government should pick up more of the bill, not that they should charge less.
- bart_spoon 4y agoNo, it means that the government and insurance companies already don’t pay what they are charging. You should look into the rebate system in the US. Pharma companies charge high sticker prices only to knock them back down to very low prices via a “rebate” for insurers. Insurers aren’t paying hundreds of dollars for the insulin that it would cost a normal consumer to buy, they are paying tens of dollars that is in line with what people expect insulin to cost.